5-hydroxymethylcytosine has been researched along with Atypical Endometrial Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Chao, TK; Chou, YC; Ko, PS; Lin, YC; Lin, YJ; Liu, NT; Perng, CL; Shang, HS; Wang, YC | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; DNA Methylation; Down-Regulation; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Mixed Function Oxygenases; Neoplasm Grading; Prognosis; Proto-Oncogene Proteins; Retrospective Studies; Survival Analysis | 2021 |